*Multiple Myeloma: An Incurable B-cell Malignancy and A Vicious Cycle of Relapse* Multiple Myeloma is a challenging and incurable B-cell malignancy characterized by the abnormal proliferation of plasma cells in the bone marrow. The disease significantly impacts patients' quality of life due to its recurrent nature and the limitations of current therapies. This article explores the incidence of Multiple Myeloma, the evolving treatment landscape, and the persistent challenges faced by patients and clinicians alike. For More https://www.delveinsight.com/blog/multiple-myeloma-market